Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma
Authors
Keywords
Sarcopenia, Skeletal muscle index (SMI), Diffuse large B-cell lymphoma (DLBCL)
Journal
ANNALS OF HEMATOLOGY
Volume 94, Issue 12, Pages 2043-2053
Publisher
Springer Nature
Online
2015-09-19
DOI
10.1007/s00277-015-2499-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy
- (2013) Hélène Lanic et al. LEUKEMIA & LYMPHOMA
- A retrospective study on 73 elderly patients (≥75years) with aggressive B-cell non Hodgkin lymphoma: Clinical significance of treatment intensity and comprehensive geriatric assessment
- (2013) Francesco Marchesi et al. Journal of Geriatric Oncology
- The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL
- (2012) C. Muller et al. BLOOD
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
- (2012) Y Kanda BONE MARROW TRANSPLANTATION
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
- (2012) Kenneth C.H. Fearon et al. Cell Metabolism
- Hypoxia-inducible factors as key regulators of tumor inflammation
- (2012) Soulafa Mamlouk et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective study
- (2012) Angelo M. Carella et al. LEUKEMIA & LYMPHOMA
- Modulated Chemotherapy According to Modified Comprehensive Geriatric Assessment in 100 Consecutive Elderly Patients with Diffuse Large B-Cell Lymphoma
- (2012) M. Spina et al. ONCOLOGIST
- The Relationships between Body Composition and the Systemic Inflammatory Response in Patients with Primary Operable Colorectal Cancer
- (2012) Colin H. Richards et al. PLoS One
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- Phase II study of the tetrahydropyranyl adriamycin–cyclophosphamide, vincristine, and prednisolone regimen combined with rituximab as first-line treatment for elderly patients with diffuse large B-cell lymphoma
- (2011) Senji Kasahara et al. LEUKEMIA & LYMPHOMA
- Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People
- (2010) A. J. Cruz-Jentoft et al. AGE AND AGEING
- Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma
- (2010) Tsuneaki Hirakawa et al. ANNALS OF HEMATOLOGY
- Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma
- (2010) S. Antoun et al. ANNALS OF ONCOLOGY
- Relationship Between Preoperative Comorbidity, Systemic Inflammatory Response, and Survival in Patients Undergoing Curative Resection for Colorectal Cancer
- (2010) C. S. D. Roxburgh et al. ANNALS OF SURGICAL ONCOLOGY
- Muscle Wasting in Cancer Cachexia: Clinical Implications, Diagnosis, and Emerging Treatment Strategies
- (2010) Shontelle Dodson et al. Annual Review of Medicine
- The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer
- (2010) C H Richards et al. BRITISH JOURNAL OF CANCER
- Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy*
- (2010) Sari Riihijärvi et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer
- (2009) B. H.L. Tan et al. CLINICAL CANCER RESEARCH
- Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
- (2009) C. M.M. Prado et al. CLINICAL CANCER RESEARCH
- Phase II study of Rituximab combined with THP-COP as first-line therapy for patients younger than 70 years with diffuse large B cell lymphoma
- (2009) Takeshi Hara et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The emerging role of computerized tomography in assessing cancer cachexia
- (2009) Carla MM Prado et al. Current Opinion in Supportive and Palliative Care
- A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care
- (2008) Marina Mourtzakis et al. Applied Physiology Nutrition and Metabolism
- The advantage of women in cancer survival: An analysis of EUROCARE-4 data
- (2008) A. Micheli et al. EUROPEAN JOURNAL OF CANCER
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
- (2008) Carla MM Prado et al. LANCET ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now